Skip to main content

MoneyWorks4Me

Sun Pharmaceutical Industries informs about press release

23 Jan 2026 Evaluate
Sun Pharmaceutical Industries has informed that it enclosed a copy of the press release titled ‘Sun Pharma receives DCGI approval to manufacture and market generic semaglutide injection in India for chronic weight management,’ which shall be released after this intimation.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1880.90
Dr. Reddys Labs. 1377.00
Cipla 1393.00
Lupin 1980.00
Zydus Lifesciences 1191.00
View more..